Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Statement [Abstract]
REVENUE	$ 398,200
Cost of Revenue	248,664
NET REVENUE	149,536
EXPENSES
General and administrative expenses [Note 5, 7, 9 and 10]	7,458,855	5,961,173
Research and development expenses	1,282,746	1,762,561
TOTAL OPERATING EXPENSES	8,741,601	7,723,734
Accretion expense [Note 5]		879,416
Change in fair value of derivative liabilities [Note 6]		20,588
NET LOSS BEFORE INCOME TAXES	(8,592,065)	(8,623,738)
Income taxes [Note 8]
NET LOSS	(8,592,065)	(8,623,738)
Translation adjustment	(111,834)	(229,745)
COMPREHENSIVE LOSS	$ (8,703,899)	$ (8,853,483)
LOSS PER SHARE, BASIC AND DILUTED	$ (0.257)	$ (0.286)
WEIGHTED AVERAGE NUMBER OF COMMON AND EXCHANGEABLE SHARES OUTSTANDING	33,376,068	30,165,638